Vineet Laboratories Ltd
VINEETLAB
Company Profile
Business description
Vineet Laboratories Ltd Formerly known as Ortin Laboratories Limited, Unit-II is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Isopropyl-beta-D-thiogalactopyranoside and Nitrophenyl phosphate disodium salt among others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, manufacture of Drug Intermediates & Bulk Dugs.
Contact
5-5-160, Malleswari Nilayam, Opposite Vishnu Theatre
Chintalakunta, L.B.Nagar
HyderabadTG500 074
INDT: +91 4024128833
Sector
Basic Materials
Stock type
Cyclical
Industry
Chemicals
Fiscal Year End
31 March 2026
Employees
79
Stocks News & Analysis
stocks
Anglo American strikes deal to create a new copper giant
We are surprised that Teck agreed to the merger on these terms, and wouldn’t be surprised if there is a twist in the tale.
stocks
The ‘other’ AI chip behemoth that might just be getting started
The magnitude of growth at Broadcom continues to astound us.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,071.40 | 9.10 | -0.10% |
| CAC 40 | 7,835.31 | 73.99 | 0.95% |
| DAX 40 | 23,744.73 | 111.78 | 0.47% |
| Dow JONES (US) | 45,935.55 | 444.63 | 0.98% |
| FTSE 100 | 9,284.08 | 58.69 | 0.64% |
| HKSE | 26,086.32 | 113.94 | -0.43% |
| NASDAQ | 21,984.57 | 98.51 | 0.45% |
| Nikkei 225 | 44,372.50 | 534.83 | 1.22% |
| NZX 50 Index | 13,229.15 | 47.09 | -0.35% |
| S&P 500 | 6,568.09 | 36.05 | 0.55% |
| S&P/ASX 200 | 8,805.00 | 8.80 | -0.10% |
| SSE Composite Index | 3,875.31 | 63.09 | 1.65% |